Gap junctions in human glioblastomas: Implications for suicide gene therapy

Cancer Gene Therapy

Volumn 18, Issue 9, 2011, Pages 674-681

  Cottin, S ^a   Gould, P V ^a   Cantin, L ^a   Caruso, M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

bystander effect; connexin43; ganciclovir; gap junction; glioblastoma; thymidine kinase

Indexed keywords

CONNEXIN 43; GANCICLOVIR; HERPESVIRUS VECTOR; LENTIVIRUS VECTOR; THYMIDINE KINASE;

ADULT; ARTICLE; BYSTANDER EFFECT; CANCER CELL CULTURE; CANCER GENE THERAPY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GAP JUNCTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE GENE THERAPY; VIRAL GENE DELIVERY SYSTEM;

AGED; CONNEXIN 43; FEMALE; FLOW CYTOMETRY; GAP JUNCTIONS; GENE THERAPY; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED;

SIMPLEXVIRUS;

EID: 80052038508     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2011.38     Document Type: Article

References (34)

1. Laird DW. Life cycle of connexins in health and disease. Biochem J 2006; 394: 527-543.
2. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002; 383: 725-737. (Pubitemid 34649891)
3. Wilgenbus KK, Kirkpatrick CJ, Knuechel R, Willecke K, Traub O. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer 1992; 51: 522-529.
4. Zhang W, Couldwell WT, Simard MF, Song H, Lin JH, Nedergaard M. Direct gap junction communication between malignant glioma cells and astrocytes. Cancer Res 1999; 59: 1994-2003. (Pubitemid 29186177)
5. Lin JH, Takano T, Cotrina ML, Arcuino G, Kang J, Liu S et al. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 2002; 22: 4302-4311. (Pubitemid 37465645)
6. Oliveira R, Christov C, Guillamo JS, Debouard S, Palfi S, Venance L et al. Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas. BMC Cell Biol 2005; 6: 7.
7. Ito A, Koma Y, Uchino K, Okada T, Ohbayashi C, Tsubota N et al. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis. Cancer Lett 2006; 234: 239-248.
8. Naoi Y, Miyoshi Y, Taguchi T, Kim SJ, Arai T, Maruyama N et al. Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers. Cancer Lett 2008; 262: 248-256.
9. Naoi Y, Miyoshi Y, Taguchi T, Kim SJ, Arai T, Tamaki Y et al. Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer. Breast Cancer Res Treat 2007; 106: 11-17. (Pubitemid 47498083)
10. Huang RP, Hossain MZ, Sehgal A, Boynton AL. Reduced connexin43 expression in high-grade human brain glioma cells. J Surg Oncol 1999; 70: 21-24. (Pubitemid 29061990)
11. Aronica E, Gorter JA, Jansen GH, Leenstra S, Yankaya B, Troost D. Expression of connexin 43 and connexin 32 gapjunction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol (Berl) 2001; 101: 449-459. (Pubitemid 32600134)
12. Soroceanu L, Manning Jr TJ, Sontheimer H. Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 2001; 33: 107-117. (Pubitemid 32160974)
13. Pu P, Xia Z, Yu S, Huang Q. Altered expression of Cx43 in astrocytic tumors. Clin Neurol Neurosurg 2004; 107: 49-54. (Pubitemid 39556679)
14. Caltabiano R, Torrisi A, Condorelli D, Albanese V, Lanzafame S. High levels of connexin 43 mRNA in high grade astrocytomas. Study of 32 cases with in situ hybridization. Acta Histochem 2010; 112: 529-535.
15. Naus CC, Laird DW. Implications and challenges of connexin connections to cancer. Nat Rev Cancer 2010; 10: 435-441.
16. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 2009; 18: 1061-1083.
17. Immonen A, Vapalahti M, Tyynela K, Hurskainen H, Sandmair A, Vanninen R et al. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 2004; 10: 967-972. (Pubitemid 39419922)
18. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281. (Pubitemid 16008301)
19. Fick J, Barker II FG, Dazin P, Westphale EM, Beyer EC, Israel MA. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc Natl Acad Sci USA 1995; 92: 11071-11075.
20. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 1996; 93: 1831-1835. (Pubitemid 26079840)
21. Dilber MS, Abedi MR, Christensson B, Bjorkstrand B, Kidder GM, Naus CC et al. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res 1997; 57: 1523-1528. (Pubitemid 27175570)
22. Czyz J, Irmer U, Schulz G, Mindermann A, Hulser DF. Gap-junctional coupling measured by flow cytometry. Exp Cell Res 2000; 255: 40-46. (Pubitemid 30115286)
23. Cottin S, Ghani K, Caruso M. Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43. Cancer Gene Ther 2008; 15: 823-831.
24. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-8471. (Pubitemid 28471781)
25. Caron MC, Caruso M. A nuclear localization signal in the matrix of spleen necrosis virus (SNV) does not allow efficient gene transfer into quiescent cells with SNV-derived vectors. Virology 2005; 338: 292-296. (Pubitemid 41019195)
26. Naus CC, Bechberger JF, Caveney S, Wilson JX. Expression of gap junction genes in astrocytes and C6 glioma cells. Neurosci Lett 1991; 126: 33-36.
27. Cottin S, Ghani K, de Campos-Lima PO, Caruso M. Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy. Mol Cancer 2010; 9: 141.
28. Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 2005; 1719: 125-145. (Pubitemid 41785641)
29. Shinoura N, Chen L, Wani MA, Kim YG, Larson JJ, Warnick RE et al. Protein and messenger RNA expression of connexin43 in astrocytomas: implications in brain tumor gene therapy. J Neurosurg 1996; 84: 839-845; discussion 846. (Pubitemid 26120099)
30. Estin D, Li M, Spray D, Wu JK. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy. Neurosurgery 1999; 44: 361-368; discussion 368-369.
31. Asklund T, Appelskog IB, Ammerpohl O, Langmoen IA, Dilber MS, Aints A et al. Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Exp Cell Res 2003; 284: 185-195. (Pubitemid 36329174)
32. Pepper MS, Montesano R, el Aoumari A, Gros D, Orci L, Meda P. Coupling and connexin 43 expression in microvascular and large vessel endothelial cells. Am J Physiol 1992; 262: C1246-C1257.
33. Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY et al. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol 2009; 94: 1-19.
34. Rainov NG. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 2000; 11: 2389-2401.